Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
As manufacturers gain real-world experience with Inflation Reduction Act price negotiations, early lessons from the first 3 cycles highlight the need for earlier planning, stronger cross-functional coordination, and new approaches to data,...
As manufacturers gain real-world experience with Inflation Reduction Act price negotiations, early lessons from the first 3 cycles highlight the need for earlier planning, stronger cross-functional coordination, and new approaches to data,...
At Asembia 2026, market access leaders warned that sweeping policy shifts—from most favored nation (MFN) pricing and Inflation Reduction Act (IRA) negotiations to pharmacy benefit manager (PBM) and 340B reform—are reshaping global pricing...
At Asembia 2026, market access leaders warned that sweeping policy shifts—from most favored nation (MFN) pricing and Inflation Reduction Act (IRA) negotiations to pharmacy benefit manager (PBM) and 340B reform—are reshaping global pricing...
At Asembia 2026, speakers highlighted how embedding specialty pharmacy care coaches into diabetes management at UMass Memorial Health is improving outcomes, reducing costs, and advancing value-based care by addressing both clinical and social...
At Asembia 2026, speakers highlighted how embedding specialty pharmacy care coaches into diabetes management at UMass Memorial Health is improving outcomes, reducing costs, and advancing value-based care by addressing both clinical and social...
At Asembia 2026, Dee Chaudhary, Principal, Commercial Strategy Consulting Life Sciences and Healthcare, Clarivate, outlined how the Inflation Reduction Act (IRA), renewed Most Favored Nation (MFN)-style pricing pressure, and broader coverage...
At Asembia 2026, Dee Chaudhary, Principal, Commercial Strategy Consulting Life Sciences and Healthcare, Clarivate, outlined how the Inflation Reduction Act (IRA), renewed Most Favored Nation (MFN)-style pricing pressure, and broader coverage...
As the 2026 midterm elections approach, the health policy landscape faces major uncertainty. This panel will explore how potential changes to congressional power-balance and state dynamics could shape key priorities like drug pricing,...
As the 2026 midterm elections approach, the health policy landscape faces major uncertainty. This panel will explore how potential changes to congressional power-balance and state dynamics could shape key priorities like drug pricing,...
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
This interview explores the structural, operational, and reimbursement challenges limiting access to cell and gene therapies, highlighting the importance of stakeholder collaboration, innovative payment models, real-world evidence, and...
This interview explores the structural, operational, and reimbursement challenges limiting access to cell and gene therapies, highlighting the importance of stakeholder collaboration, innovative payment models, real-world evidence, and...
In this interview, Deborah Patt, MD, PhD, MBA, discusses data presented at the 2026 American Society of Clinical Oncology Annual Meeting showing how electronic patient-reported outcomes and remote therapeutic monitoring can improve symptom...
In this interview, Deborah Patt, MD, PhD, MBA, discusses data presented at the 2026 American Society of Clinical Oncology Annual Meeting showing how electronic patient-reported outcomes and remote therapeutic monitoring can improve symptom...
Presenters at ISPOR 2026 demonstrated how integrating mortality data from multiple sources can substantially improve death ascertainment and strengthen the validity of real-world evidence for research and decision-making.
Presenters at ISPOR 2026 demonstrated how integrating mortality data from multiple sources can substantially improve death ascertainment and strengthen the validity of real-world evidence for research and decision-making.
Experts at ISPOR 2026 explored how generative AI may overcome longstanding challenges in medical device identification, enabling more accurate and scalable real-world evidence generation from unstructured clinical data.
Experts at ISPOR 2026 explored how generative AI may overcome longstanding challenges in medical device identification, enabling more accurate and scalable real-world evidence generation from unstructured clinical data.
Experts at ISPOR 2026 highlighted how registries, linked data sources, and research collaborations can generate real-world evidence that bridges clinical evidence gaps for medical devices and diagnostics when traditional trials are not...
Experts at ISPOR 2026 highlighted how registries, linked data sources, and research collaborations can generate real-world evidence that bridges clinical evidence gaps for medical devices and diagnostics when traditional trials are not...
Researchers found that AI-powered analysis of thousands of Reddit posts can identify unmet needs, symptom burdens, and care challenges among patients with systemic lupus erythematosus, highlighting the potential of social media listening to...
Researchers found that AI-powered analysis of thousands of Reddit posts can identify unmet needs, symptom burdens, and care challenges among patients with systemic lupus erythematosus, highlighting the potential of social media listening to...
The growing use of prior authorization continues to create challenges for patients and providers, but experts at ISPOR 2026 outlined policy reforms and emerging AI-driven solutions that could improve transparency, efficiency, and access to...
The growing use of prior authorization continues to create challenges for patients and providers, but experts at ISPOR 2026 outlined policy reforms and emerging AI-driven solutions that could improve transparency, efficiency, and access to...
A forum at ISPOR 2026 highlighted how HEOR leaders can drive organizational growth by translating complex value evidence into strategic insights that resonate with C-suite priorities.
A forum at ISPOR 2026 highlighted how HEOR leaders can drive organizational growth by translating complex value evidence into strategic insights that resonate with C-suite priorities.
In this interview, a guest expert discusses research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on how the growing use of oral oncolytics and the increasing prevalence of concurrent cancers may expose...
In this interview, a guest expert discusses research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on how the growing use of oral oncolytics and the increasing prevalence of concurrent cancers may expose...
Suzanne Watnick, MD, explains why earlier chronic kidney disease detection, broader access to proven therapies, and reimbursement policies that support innovation are critical to improving kidney care outcomes and reducing progression to...
Suzanne Watnick, MD, explains why earlier chronic kidney disease detection, broader access to proven therapies, and reimbursement policies that support innovation are critical to improving kidney care outcomes and reducing progression to...
Suzanne Watnick, MD, explains...
05/29/2026
First Report Managed Care
Asembia is an industry leader in the specialty pharmacy sector. It aims to connect and strengthen the pharmaceutical industry and transform its ideas into significant innovations, all dedicated to optimizing and improving patients' experiences worldwide. Visit asembia.com for more information.
